RCW 69.51.020
Legislative purpose.
The legislature finds that recent research has shown that the use of cannabis may alleviate the nausea and ill effects of cancer chemotherapy and radiology, and, additionally, may alleviate the ill effects of glaucoma. The legislature further finds that there is a need for further research and experimentation regarding the use of cannabis under strictly controlled circumstances. It is for this purpose that the controlled substances therapeutic research act is hereby enacted.
[ 2022 c 16 § 112; 1979 c 136 § 2.]
NOTES:
Intent—Finding—2022 c 16: See note following RCW 69.50.101.
Structure Revised Code of Washington
Title 69 - Food, Drugs, Cosmetics, and Poisons
Chapter 69.51 - Controlled Substances Therapeutic Research Act.
69.51.020 - Legislative purpose.
69.51.040 - Controlled substances therapeutic research program.
69.51.050 - Patient qualification review committee.
69.51.060 - Sources and distribution of cannabis.
69.51.080 - Cannabis and related products considered Schedule II substances.